Newsroom

Sorted by: Latest

-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 13.03.2026 FEUD IE00BF2FL590  359,454.00 EUR  18,578,880.97   51.686  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 13.03.2026 FEUZ IE00B8X9NY41 1,959,822.00 EUR 114,169,552.43   58.255  ...
-

Alto Neuroscience Reports Full Year 2025 Financial Results and Recent Business Highlights

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today reported financial results for the full year ended December 31, 2025, and highlighted recent progress across its pipeline of clinical-stage product candidates. “Alto enters 2026 with a very strong clinical and financial foundation,” said Amit Etkin, M.D., Ph.D., founder and...
-

Havas Reports the Progress of Transactions under Its Current Share Buyback Program

PARIS--(BUSINESS WIRE)--Havas reports the progress of transactions under its current share buyback program...
-

WaterBridge Announces Fourth Quarter and Fiscal Year 2025 Results

HOUSTON--(BUSINESS WIRE)--WaterBridge Infrastructure LLC (NYSE: WBI) (the “Company” or “WaterBridge”) today announced its financial and operating results for the fourth quarter and fiscal year ended December 31, 2025. Prior to the closing of WaterBridge's initial public offering (the "IPO") on September 18, 2025, WaterBridge completed the successful combination (the "Combination") of its legacy entities WaterBridge Equity Finance LLC ("WBEF"), WaterBridge NDB Operating LLC ("NDB Operating") and...
-

Maple Partners with Shift4 to Bring AI Phone Ordering to SkyTab Restaurants

NEW YORK--(BUSINESS WIRE)--Maple, the leading voice AI platform for restaurants, today announced that it has integrated its solution with Shift4 (NYSE: FOUR), a global leader in integrated payments and commerce technology, to bring 24/7 AI-powered phone ordering to restaurant merchants using SkyTab POS nationwide. The partnership integrates Maple's voice AI directly with SkyTab, addressing the persistent challenge of missed phone calls and lost revenue facing restaurant operators. With over 40%...
-

WisdomTree to Acquire Atlantic House Holdings Limited, Expanding Global ETF Lineup with Defined Outcome and Derivatives Capabilities

NEW YORK & LONDON--(BUSINESS WIRE)--WisdomTree has entered into a definitive agreement to acquire Atlantic House Holdings Limited....
-

NUBURU Issues Letter to its Shareholders

DENVER--(BUSINESS WIRE)--NUBURU, Inc. (NYSE American: BURU), a dual-use Defense & Security platform company focused on non-kinetic effects, directed-energy technologies, electronic warfare and software-orchestrated defense systems, today issued a letter to its shareholders. Dear Fellow Shareholders, On behalf of the Board of Directors and the entire management team of NUBURU, Inc., I would like to sincerely thank our Shareholders for their participation and support at the Special Meeting of...
-

Experian Marks a Breakthrough in Consumer AI with the Next Evolution of Its Virtual Assistant

COSTA MESA, Calif.--(BUSINESS WIRE)--Experian today unveiled the next evolution of the Experian Virtual Assistant, EVA™, a significant advancement in its Consumer First AI strategy....
-

Two Publications Highlight Clinical Utility of Signatera™ in Anal and Rectal Cancers

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced two peer-reviewed publications highlighting the clinical utility of Signatera, its personalized, tumor-informed circulating tumor DNA (ctDNA) assay, in anal squamous cell carcinoma (ASCC) and locally advanced rectal cancer (LARC). ASCC: publication in Nature Communications A recently published study evaluated 84 patients with ASCC to assess whether serial Signate...